Evolving pancreatic cancer treatment: From diagnosis to healthcare management-Reference-Cited by-同舟云学术

Evolving pancreatic cancer treatment: From diagnosis to healthcare management

Published:2022-01 Issue: Volume:169 Page:103571
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Milella Michele,Bassi Claudio,Boggi Ugo^ORCID,Brunetti Oronzo,Cavaliere Alessandro^ORCID,Crippa Stefano,De Vita Ferdinando,Falconi Massimo,Frassineti Giovanni Luca,Giommoni Elisa,Macchini Marina^ORCID,Malleo Giuseppe,Silvestris Nicola,Tudisco Antonella,Vasile Enrico^ORCID,Reni Michele

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference206 articles.

1. Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease;Abdel-Misih;Ann. Surg. Oncol.,2011

2. Combined modality treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement;Abrams;Ann. Surg. Oncol.,2009

3. Hepatic resection for non-colorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model;Adam;Ann. Surg.,2006

4. Real-time genomic characterization of advanced pancreatic Cancer to enable precision medicine;Aguirre;Cancer Discov.,2018

5. Effect of centralization on long-term survival after resection of pancreatic ductal adenocarcinoma;Ahola;Br. J. Surg.,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer;Nucleosides, Nucleotides & Nucleic Acids;2024-02-29

2. Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy;Digestive and Liver Disease;2024-02

3. ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells;Journal of Experimental & Clinical Cancer Research;2024-01-02

4. Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer;Surgery;2023-12

5. Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer;Seminars in Cancer Biology;2023-12